Multicenter European External Validation of a Prostate Health Index–based Nomogram for Predicting Prostate Cancer at Extended Biopsy-Reference-Cited by-同舟云学术

Multicenter European External Validation of a Prostate Health Index–based Nomogram for Predicting Prostate Cancer at Extended Biopsy

Published:2014-11 Issue:5 Volume:66 Page:906-912
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Lughezzani Giovanni,Lazzeri Massimo,Haese Alexander,McNicholas Thomas,de la Taille Alexandre,Buffi Nicolò Maria,Fossati Nicola,Lista Giuliana,Larcher Alessandro,Abrate Alberto,Mistretta Alessandro,Bini Vittorio,Palou Redorta Joan,Graefen Markus,Guazzoni Giorgio

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer;Heijnsdijk;Br J Cancer,2009

2. A multicenter study of [−2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range;Catalona;J Urol,2011

3. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting;Guazzoni;Eur Urol,2011

4. Prostate-specific antigen (PSA) isoform p2PSA in combination with total PSA and free PSA improves diagnostic accuracy in prostate cancer detection;Jansen;Eur Urol,2010

5. Serum index test %[−2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy;Lazzeri;J Urol,2012

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 2‐year prospective evaluation of the Prostate Health Index in guiding biopsy decisions in a large cohort;BJU International;2024-07-04

2. Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions;Technology in Cancer Research & Treatment;2024-01

3. Urinary exosomal prostate‐specific antigen is a noninvasive biomarker to detect prostate cancer: Not only old wine in new bottles;International Journal of Cancer;2022-12-12

4. MRI-measured adipose features as predictive factors for detection of prostate cancer in males undergoing systematic prostate biopsy: a retrospective study based on a Chinese population;Adipocyte;2022-11-24

5. Lesion Volume in a Bi- or Multivariate Prediction Model for the Management of PI-RADS v2.1 Score 3 Category Lesions;Türk Üroloji Dergisi/Turkish Journal of Urology;2022-07-28